Skip to content

Clinical trials

Recruiting Phase 1 Macular Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 1 Status: Recruiting Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20222
20231
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Institute for Regenerative Medicine2
Aptabio Therapeutics, Inc.1
Arrowhead Pharmaceuticals1
Beijing Tongren Hospital1
Benobio Co., Ltd.1
Caregen Co. Ltd.1
Cellio Therapeutics Inc1
MCPHS University1
MediBeacon1
Regeneron Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration13
Geographic Atrophy3
Stargardt Disease3
Diabetic Retinopathy2
Retinal Diseases2
Retinitis Pigmentosa2
Alcoholism1
Eye Diseases1
Optic Atrophy1
Optic Nerve Injuries1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.